Following the announcement, the med-tech company’s shares fell as much as 5 percent from its $17.77 close on Tuesday.
Health Care + Med Tech
Blueprint Bio’s biomarker discovery platform taps personalized medicine momentum.
The first day of business coincides with the state adding intractable pain to the list of qualifying conditions.
The company’s purchase of HeartWare is an attempt to gain market share in an $800 million heart failure device market.
The hospital will provide emergency services during events.
Leave the weight-loss program. Take the standing desk.
Medical device firm would be first Minnesota IPO in nearly 18 months.
Mayo Clinic ranked as the runner-up on the national list.
The health organization hopes its latest collaboration will lead to more website traffic and a higher level of brand awareness.
A look at the Rochester clinic’s Top 10 National Institutes of Health awards.
Florida-based TapImmune exercises option, readies Phase II trials for HER2/neu cancer immunotherapy platform.
The medical device company also has another $25 million in the pipeline pending “the company’s achievement of a certain milestone.”
Regenerative, individualized medicine researchers seem likely picks for new Rochester buildings.
The addition of this testing method will shape future studies and could help doctors predict a patient’s chance of suffering from chronic disease.
Possible strike looms amid health plan dispute.
Developer Ryan Companies seeing health care demand.
The company faces over 36,000 lawsuits surrounding issues with the devices.
It’s all about priorities – and the price of health care doesn’t seem to be one of them.